EM Phase I Safety Report

I’ll give you a complete event description that occurred during a Phase I clinical trial whose core aim is to evaluate safety. Using that source text, I need a concise yet regulator-ready EM pharmaceutical investigation report. Your task is to transform the narrative I provide into a structured document that: • summarises the incident clearly, • details the immediate and root-cause analyses, • outlines corrective and preventive actions, and • frames everything within current ICH-GCP and FDA safety-reporting expectations. Please deliver the final investigation as a Word document with numbered sections and clean, professional language. A brief cover memo highlighting key safety findings and next-step recommendations should accompany the main report. I will review the draft once; after my comments are incorporated, the assignment is complete.